Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice

被引:184
|
作者
Kumari, Pratima [1 ]
Rothan, Hussin A. [1 ]
Natekar, Janhavi P. [1 ]
Stone, Shannon [1 ]
Pathak, Heather [1 ]
Strate, Philip G. [1 ]
Arora, Komal [1 ]
Brinton, Margo A. [1 ]
Kumar, Mukesh [1 ]
机构
[1] Georgia State Univ, Dept Biol, Coll Arts & Sci, Atlanta, GA 30303 USA
来源
VIRUSES-BASEL | 2021年 / 13卷 / 01期
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; COVID-19; K18-hACE2; mice; neuroinvasion; neuroinflammation; encephalitis; MOUSE HEPATITIS-VIRUS; VIRAL DISEASES; OLFACTORY-BULB; INFECTION; CORONAVIRUS; BRAIN; MODEL; PATHOGENESIS; DYSFUNCTION; DEFENSE;
D O I
10.3390/v13010132
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can cause neurological disease in humans, but little is known about the pathogenesis of SARS-CoV-2 infection in the central nervous system (CNS). Herein, using K18-hACE2 mice, we demonstrate that SARS-CoV-2 neuroinvasion and encephalitis is associated with mortality in these mice. Intranasal infection of K18-hACE2 mice with 10(5) plaque-forming units of SARS-CoV-2 resulted in 100% mortality by day 6 after infection. The highest virus titers in the lungs were observed on day 3 and declined on days 5 and 6 after infection. By contrast, very high levels of infectious virus were uniformly detected in the brains of all the animals on days 5 and 6. Onset of severe disease in infected mice correlated with peak viral levels in the brain. SARS-CoV-2-infected mice exhibited encephalitis hallmarks characterized by production of cytokines and chemokines, leukocyte infiltration, hemorrhage and neuronal cell death. SARS-CoV-2 was also found to productively infect cells within the nasal turbinate, eye and olfactory bulb, suggesting SARS-CoV-2 entry into the brain by this route after intranasal infection. Our data indicate that direct infection of CNS cells together with the induced inflammatory response in the brain resulted in the severe disease observed in SARS-CoV-2-infected K18-hACE2 mice.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice
    Wong, Ting Y.
    Horspool, Alexander M.
    Russ, Brynnan P.
    Ye, Chengjin
    Lee, Katherine S.
    Winters, Michael T.
    Bevere, Justin R.
    Miller, Olivia A.
    Rader, Nathaniel A.
    Cooper, Melissa
    Kieffer, Theodore
    Sourimant, Julien
    Greninger, Alexander L.
    Plemper, Richard K.
    Denvir, James
    Cyphert, Holly A.
    Barbier, Mariette
    Torrelles, Jordi B.
    Martinez, Ivan
    Martinez-Sobrido, Luis
    Damron, F. Heath
    JOURNAL OF VIROLOGY, 2022, 96 (06)
  • [32] Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
    Aw, Zhen Qin
    Mok, Chee Keng
    Wong, Yi Hao
    Chen, Huixin
    Mak, Tze Minn
    Lin, Raymond T. P.
    Lye, David Chien
    Tan, Kai Sen
    Chu, Justin Jang Hann
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] Bacillus Calmette-Guerin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice
    Zhang, Bao-Zhong
    Shuai, Huiping
    Gong, Hua-Rui
    Hu, Jing-Chu
    Yan, Bingpeng
    Yuen, Terrence Tsz-Tai
    Hu, Ye-Fan
    Yoon, Chaemin
    Wang, Xiao-Lei
    Hou, Yuxin
    Lin, Xuansheng
    Huang, Xiner
    Li, Renhao
    Au-Yeung, Yee Man
    Li, Wenjun
    Hu, Bingjie
    Chai, Yue
    Yue, Ming
    Cai, Jian-Piao
    Ling, Guang Sheng
    Hung, Ivan Fan-Ngai
    Yuen, Kwok-Yung
    Chan, Jasper Fuk-Woo
    Huang, Jian-Dong
    Chu, Hin
    JCI INSIGHT, 2022, 7 (11)
  • [34] The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2
    Xu, Jiali
    Wu, Zifeng
    Zhang, Mi
    Liu, Shijiang
    Zhou, Ling
    Yang, Chun
    Liu, Cunming
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [35] Differential Outcomes of Infection by Wild-Type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 Variants of Concern in K18-hACE2 Transgenic Mice
    He, Yicheng
    Henley, Jill
    Sell, Philip
    Comai, Lucio
    VIRUSES-BASEL, 2024, 16 (01):
  • [36] Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
    Clever, Sabrina
    Limpinsel, Leonard
    zu Natrup, Christian Meyer
    Schuenemann, Lisa-Marie
    Beythien, Georg
    Rosiak, Malgorzata
    Huelskoetter, Kirsten
    Gregor, Katharina Manuela
    Tuchel, Tamara
    Kalodimou, Georgia
    Freudenstein, Astrid
    Kumar, Satendra
    Baumgaertner, Wolfgang
    Sutter, Gerd
    Tscherne, Alina
    Volz, Asisa
    VIRUSES-BASEL, 2024, 16 (03):
  • [37] The severity of SARS-CoV-2 infection in K18-hACE2 mice is attenuated by a novel steroid-derivative in a gender-specific manner
    Gupte, Sachin A.
    Bakshi, Chandra Shekhar
    Blackham, Emma
    Duhamel, Gerald E.
    Jordan, Allan
    Salgame, Padmini
    D'silva, Melinee
    Khan, Mohammad Y.
    Nadler, Jerry
    Gupte, Rakhee
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (20) : 2677 - 2693
  • [38] RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
    Wong, Ting Y.
    Russ, Brynnan P.
    Lee, Katherine S.
    Miller, Olivia A.
    Kang, Jason
    Cooper, Melissa
    Winters, Michael T.
    Rodriguez-Aponte, Sergio A.
    Dalvie, Neil C.
    Johnston, Ryan S.
    Rader, Nathaniel A.
    Wong, Zeriel Y.
    Cyphert, Holly A.
    Martinez, Ivan
    Shaligram, Umesh
    Batwal, Saurabh
    Lothe, Rakesh
    Chandrasekaran, Rahul
    Nagar, Gaurav
    Rajurkar, Meghraj
    Rao, Harish
    Bevere, Justin R.
    Barbier, Mariette
    Love, J. Christopher
    Damron, F. Heath
    MSPHERE, 2022, 7 (04)
  • [39] Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
    Paull, Jeremy R. A.
    Luscombe, Carolyn A.
    Castellarnau, Alex
    Heery, Graham P.
    Bobardt, Michael D.
    Gallay, Philippe A.
    VIRUSES-BASEL, 2021, 13 (08):
  • [40] Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine
    Myeni, Sebenzile K.
    Leijs, Anouk A.
    Bredenbeek, Peter J.
    Morales, Shessy Torres
    Linger, Marissa E.
    Fougeroux, Cyrielle
    van Zanen-Gerhardt, Sophie
    Zander, Serge A. L.
    Sander, Adam F.
    Kikkert, Marjolein
    VACCINES, 2024, 12 (07)